Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

FD acquires QuantumKDB

12 Jan 2016 07:00

RNS Number : 5189L
First Derivatives PLC
12 January 2016
 

12 January 2016

 

First Derivatives plc

("FD", the "Company" or the "Group")

 

FD acquires QuantumKDB

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces that it has acquired the entire issued share capital of QuantumKDB (UK) Limited ("Quantum") for total consideration of up to £2.2m. The acquisition provides the Group with complementary consultancy expertise to support the growth of its Kx business and is expected to be earnings enhancing in the first full year following acquisition*.

 

Acquisition rationale

 

Quantum was founded in 2011 by its CEO Kieran Lucid and provides Kx consulting in the UK, US and Hong Kong. The majority of its clients operate in capital markets and the acquisition will strengthen the Group's relationship with certain key clients as well as adding to the existing customer base. Quantum has a total of 15 consultants with strong experience in Kx technology. In its latest financial year to 13 September 2015, Quantum reported profit before tax of £0.3m and had net assets of £0.25m at acquisition.

 

Terms of the Acquisition

 

The initial consideration for the acquisition is £1.7m of which £0.6m is payable in cash and £1.1m is payable through the issue of 72,940 new ordinary shares in FD (the "Consideration Shares"). Deferred consideration of up to £0.5m is payable on the achievement of certain targets on the 12 month anniversary of the acquisition.

 

Application has been made for the 72,940 Consideration Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 15 January 2016. The Consideration Shares will rank pari passu with the Company's existing ordinary shares in issue. Following this allotment, the total issued share capital of the Company will increase to 23,921,972 ordinary shares.

 

Kieran Lucid, Chief Executive Officer of Quantum, commented: "As the home of Kx technology, FD is a natural fit for us. We are joining at a time of rapid expansion in the Kx client base across industry sectors, as more and more clients appreciate the benefits of this technology that has dominated capital markets for more than 10 years. We are excited about drawing on the expertise we've gained to assist the Group in its ambitious plans for the future."

 

Brian Conlon, Chief Executive Officer of FD, commented: "We are experiencing increasing demand for Kx skills from existing and potential customers and the acquisition of Quantum will add to our existing capabilities and support our growth plans. We welcome its staff to the Group."

 

\* This statement does not constitute a profit forecast.

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc

(Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAEFFFELKEAF
Date   Source Headline
6th Jun 20177:00 amRNSEnterprise Securities Market Notice
2nd Jun 20179:56 amRNSAnnual Report 2016/17 and AGM Notice
30th May 20175:13 pmRNSDirector/PDMR Shareholding
30th May 20175:12 pmRNSDirector/PDMR Shareholding
30th May 20172:06 pmRNSIssue of Equity from exercise of Share Options
16th May 20177:00 amRNSFinal Results
15th May 20175:09 pmRNSAppointment and Directorate Change
24th Apr 20177:00 amRNSTrading Update and Notice of Results
3rd Apr 201710:28 amRNSTotal Voting Rights
20th Mar 20177:00 amRNSEnterprise Securities Market Notice
14th Mar 20174:39 pmRNSIssue of Equity
14th Mar 20177:00 amRNSCollaboration Agreement with Airbus
2nd Mar 20177:00 amRNSContract Win
28th Feb 201710:09 amRNSTotal Voting Rights
7th Feb 20177:00 amRNSEnterprise Securities Market Notice
1st Feb 20173:54 pmRNSIssue of Equity
30th Dec 201610:57 amRNSTotal Voting Rights
23rd Dec 20167:00 amRNSEnterprise Securities Market Notice
19th Dec 20164:06 pmRNSIssue of Equity
7th Dec 20161:26 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSEnterprise Securities Market Notice
1st Dec 20164:52 pmRNSIssue of Equity from exercise of Share Options
30th Nov 201612:21 pmRNSTotal Voting Rights
8th Nov 20167:00 amRNSEntry into Retail Analytics market
8th Nov 20167:00 amRNSEnterprise Securities Market Notice
3rd Nov 20164:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:20 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:19 pmRNSDirector/PDMR Shareholding
1st Nov 20166:13 pmRNSIssue of Equity
1st Nov 20167:00 amRNSHalf Yearly Report
19th Oct 20167:00 amRNSNotice of Interim Results
30th Sep 20169:53 amRNSTotal Voting Rights
14th Sep 20167:00 amRNSEnterprise Securities Market Notice
7th Sep 20162:15 pmRNSIssue of Equity from exercise of Share Options
29th Jul 20161:29 pmRNSTotal Voting Rights
20th Jul 20164:59 pmRNSDirector Shareholding - AMENDMENT
19th Jul 20165:03 pmRNSDirector Shareholding
12th Jul 20167:00 amRNSDirector/PDMR Shareholding
30th Jun 20168:05 amRNSTotal Voting Rights
23rd Jun 20162:06 pmRNSResult of AGM
15th Jun 20167:00 amRNSDirector/PDMR Shareholding
6th Jun 201612:00 pmRNSIssue of Equity from exercise of Share Options
3rd Jun 20163:45 pmRNSAnnual Report 2015/16 and AGM Notice
19th May 20165:11 pmRNSHolding(s) in Company
17th May 20167:00 amRNSFinal Results
13th May 20164:38 pmRNSDirectorate Change
27th Apr 20167:00 amRNSStrategic Partnership with Thomson Reuters
26th Apr 20167:00 amRNSNotice of Results
4th Apr 20167:00 amRNSTrading Update
31st Mar 20164:44 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.